| Patents for C07J 51 - Normal steroids with unmodified cyclopenta[a]hydrophenanthrene skeleton not provided for in groups (1,565) |
|---|
| 08/09/2006 | CN1816560A Novel fusidic acid derivatives |
| 08/08/2006 | US7087591 21-substituted progesterone derivatives as new antiprogestational agents |
| 08/03/2006 | US20060173201 Process for the produciton of tibolone |
| 07/27/2006 | US20060166903 Phosphocholine linked prodrug derivatives |
| 07/26/2006 | EP1682156A1 Strontium-based complexes, pharmaceutical compositions and dietetic products |
| 07/26/2006 | EP1513863B1 Platinum complexes containing chemically modified bile acids, having antitumor activity |
| 07/11/2006 | US7074778 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 06/29/2006 | US20060140816 Sterilization of beclomethasone drug particles for pulmonary delivery |
| 06/27/2006 | US7067682 6,7-Oxygenated steroids and uses related thereto |
| 06/27/2006 | US7067326 Binding particle for use in the biosynthesis and separation of particles in sample |
| 06/15/2006 | US20060128678 Manganese based organometallic complexes, pharmaceutical compositions and dietetic products |
| 05/31/2006 | CN1780849A Process for the production of tibolone |
| 05/24/2006 | EP1658305A1 Novel fusidic acid derivatives |
| 05/18/2006 | WO2006053255A2 Novel betulin derivatives, preparation thereof and use thereof |
| 05/04/2006 | US20060094696 Oestrogen derivatives as inhibitors of steroid sulphatase |
| 05/03/2006 | CN1254479C 3-methylene steroid derivative |
| 04/13/2006 | US20060079486 Lipopolymer conjugates |
| 03/21/2006 | CA2124932C Sex steroid activity inhibitors |
| 03/08/2006 | EP1240179B1 3-methylene steroid derivatives for the treatment of autoimmune diseases |
| 02/23/2006 | US20060039963 Lipid-analogo phosphoric acid triesters |
| 01/31/2006 | CA2372066C Process for phosphorylation of primary fatty alcohols,secondary alcohols and aromatic alcohols using p4o10 in the absence of solvent |
| 01/18/2006 | CN1237071C Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease |
| 01/10/2006 | CA2425841C Angiostatic steroids |
| 12/28/2005 | EP1608670A1 Process for the production of tibolone |
| 11/30/2005 | EP1599233A2 Sterilization of beclomethasone drug particles for pulmonary delivery |
| 11/09/2005 | EP1019365B1 Novel compositions for the delivery of negatively charged molecules |
| 10/20/2005 | US20050234232 Novel compositions for the delivery of negatively charged molecules |
| 10/12/2005 | CN1681514A A method of treating diabetes mellitus including conditions associated with diabetes mellitus and complications of diabetes mellitus |
| 10/06/2005 | US20050222098 Regulation of meiosis |
| 10/06/2005 | US20050222056 Heterocyclic compounds and their use in the detection of nucleic acids |
| 09/28/2005 | CN1220696C 16 alpha-methyl or ethyl substituted estrogens |
| 09/27/2005 | US6949533 use in treating asthma, allergy, arthritis and thrombosis |
| 08/31/2005 | CN1662549A Glucocorticoid receptor ligands for the treatment of metabolic disorders |
| 08/24/2005 | EP1504019B1 Platinum complexes having antitumor activity |
| 08/11/2005 | DE102004032781A1 New lipid-modified bis-phosphonic acid derivatives, useful e.g. for transporting therapeutic or diagnostic agents, with affinity for bone, also as corrosion inhibitors |
| 08/10/2005 | CN1653082A Platinum complexes having antitumor activity |
| 08/04/2005 | WO2005070952A1 Lipid- derivatized bisphosphonic acid |
| 08/04/2005 | US20050171075 Substitued 19-nor-cholestenes; antineoplastic agents, wound healing agents, antiinflammatory agents; autoimmune diseases, transplant rejection inhibition, hyperplasia, graft versus host disease; increased cell growth modulation and differentiation, low calcemic activity |
| 08/03/2005 | EP1287017B1 2-substituted pregna-1,3,5(10)-triene and chola-1,3,5(10)-triene derivatives and their biological activity |
| 07/27/2005 | EP1556391A2 Lipid-analog phosphoric acid triester |
| 07/19/2005 | US6919439 Derivatized oligonucleotides having improved uptake and other properties |
| 07/13/2005 | EP1551860A1 Glucocorticoid receptor ligands for the treatment of metabolic disorders |
| 07/13/2005 | CN1637016A Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11 |
| 06/30/2005 | US20050143365 Structural modification of 19-norprogesterone I: 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents |
| 06/30/2005 | US20050143364 21-Substituted progesterone derivatives as new antiprogestational agents |
| 06/02/2005 | WO2005049038A1 Strontium-based complexes, pharmaceutical compositions and dietetic products |
| 06/02/2005 | CA2545082A1 Strontium-based complexes, pharmaceutical compositions and dietetic products |
| 05/31/2005 | US6900297 A compound which hybridizes with a nucleic acid includes multiple inked nucleosides (inlcudes a pentofuranosyl sugar portion and a base portion), and at least one sugar o-is terminated with R-N(R1a R1b) substitutent |
| 05/31/2005 | US6900193 Urogential disorders; antitumor agents; hormone inhibitor |
| 05/26/2005 | US20050113352 Platinum complexes containing chemically modified bile acids, having antitumor activity |
| 05/19/2005 | US20050107337 Platinum complexes having antitumor activity |
| 05/18/2005 | EP1224204B1 Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11 |
| 05/04/2005 | EP1307471B1 16alpha-methyl or ethyl substituted estrogens |
| 04/28/2005 | US20050090476 by protecting the hydroxy group of the steroid with a trialkylsilyl group, then followed a copper mediated 1,6-conjugate addition of a grignard reagent to a 4,6-unsaturated 3-ketosteroid, to yield chemical intermediates used in hormone replacement therapy |
| 04/27/2005 | CN1198656C Dual action 2', 5'-oligoadenylate antiviral derivatives and uses thereof |
| 04/26/2005 | CA2123052C Monomeric bile acid derivatives, processes for their preparation and the use of these compounds as medicaments |
| 04/19/2005 | US6881730 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy |
| 04/05/2005 | US6875859 Heterocyclic compounds and their use in the detection of nucleic acids |
| 04/05/2005 | CA2170286C Synthesis of 17-(3-pyridyl) steroids |
| 03/29/2005 | CA2100514C 17-spiromethylene steroids |
| 03/17/2005 | WO2005007669A8 Novel fusidic acid derivatives |
| 03/16/2005 | EP1513863A2 Platinum complexes containing chemically modified bile acids, having antitumor activity |
| 03/16/2005 | EP0716604B1 Thiol-derivatized nucleosides and oligonucleosides |
| 03/02/2005 | EP1155023B1 Chelating compounds and their complexes with paramagnetic metals |
| 03/01/2005 | US6861415 Antagonize endogenous progesterone to induce menses or labor, treat endometriosis, dysmenorrhea; endocrine hormone-dependent tumors, and uterine fibroids, inhibit uterine endometrial proliferation and for contraception |
| 02/16/2005 | CN1189176C Astragalus root methyl-glycoside composition and preparation method |
| 02/09/2005 | EP1504019A1 Platinum complexes having antitumor activity |
| 01/27/2005 | WO2005007669A1 Novel fusidic acid derivatives |
| 01/27/2005 | CA2532725A1 Novel fusidic acid derivatives |
| 01/25/2005 | CA2188981C Isomerisation of equilin |
| 01/19/2005 | CN1185249C Non-aromatic estrogenic steroids with hydrocarbon substituent in position 11 |
| 01/13/2005 | WO2003095462A3 Platinum complexes containing chemically modified bile acids, having antitumor activity |
| 12/08/2004 | EP1482950A1 A method of treating diabetes mellitus including conditions associated with diabetes mellitus and complications of diabetes mellitus |
| 11/18/2004 | WO2004078102A3 Sterilization of beclomethasone drug particles for pulmonary delivery |
| 10/27/2004 | EP1470151A1 Process for the preparation of 7-alpha-methylsteroids |
| 09/30/2004 | DE4120124B4 Verfahren zur Herstellung von Derivaten des Cholesterols und seiner Homologen Process for the preparation of derivatives of cholesterol and its homologues |
| 09/29/2004 | EP1178994A4 Improved process for phosphorylation and compounds produced by this process |
| 09/28/2004 | US6797522 Solid phase synthesis; libraries; enzyme inhibitors; chromatography |
| 09/16/2004 | WO2004078774A1 Process for the production of tibolone |
| 09/16/2004 | WO2004078102A2 Sterilization of beclomethasone drug particles for pulmonary delivery |
| 09/16/2004 | CA2517934A1 Process for the production of tibolone |
| 09/08/2004 | EP1454636A1 Sterilization of glucocorticoid drug particles for pulmonary delivery |
| 09/02/2004 | WO2004031199A3 Lipid-analog phosphoric acid triester |
| 08/31/2004 | US6783931 Amine-derivatized nucleosides and oligonucleosides |
| 08/25/2004 | EP1003553B1 The use of angiostatic steroids in photodynamic therapy |
| 08/19/2004 | US20040162425 6,7-Oxygenated steroids and uses related thereto |
| 08/18/2004 | EP1189924B1 Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease |
| 08/12/2004 | US20040157814 6, 7-Oxygenated steroids and uses related thereto |
| 08/11/2004 | CN1161363C Diphosphonic acid salts for treatment of osteoporsis |
| 08/10/2004 | CA2102400C Method for making 3.alpha.-hydroxy, 3.beta.-substituted-pregnanes |
| 07/29/2004 | US20040147494 Use |
| 07/22/2004 | US20040142899 Compositions and methods for enhanced biostability and altered biodistribution of oligonucleotides in mammals |
| 07/21/2004 | CN1158297C Steroid compounds with C17-alkyl side chain and aromatic A-ring for use in therapy |
| 07/21/2004 | CN1158274C Benzopyran-containing compounds and method for their use |
| 06/22/2004 | US6753423 For preferentially modulated gene expression in liver and associated tissues |
| 06/16/2004 | CN1153778C Bile acid salts of metals with physiological action and the use thereof in therapy |
| 06/09/2004 | EP1426352A2 Intermediates for the sythesis of vitamin D and steroid derivatives |
| 05/26/2004 | CN1151161C Medicine nitrate salts |
| 05/19/2004 | EP1420026A2 Use of conjugates of phytosterol or phytostanol with ascorbic acid in treating or preventing cardiovascular disease, and compositions thereof |
| 05/06/2004 | EP0775155B1 Estra-1,3,5(10)-triene derivatives, methods of preparing such compounds and pharmaceutical compositions containing them |